This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These chemicals are everywhere and have been used in many ways over the decades, bringing a range of benefits from water- and stain-resistant coatings and firefighting foams to nail polish and food packaging. However, the world is now learning they are also persistent pollutants that contaminate our soil, water and air. CHEM Trust.
Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. Not All Pharmacies Can Exempt from The 11/27/2024 DSCSA Requirements. The original article can be found HERE. The DSCSA Adventure continues. The DSCSA Adventure continues.
While DSCSA (the Drug Supply Chain Security Act) enforcement is postponed until November 2024, it is critical to move forward in becoming compliant sooner rather than later. This tracking involves the use of unique product identifiers, such as serial numbers and barcodes, on drug packaging to track their movement.
In 2021 I enrolled in a Master’s for Microbiology and cell science at the University of Florida and I am expecting to complete it in December of 2024. Not being afraid to communicate with people has been important to my success. I think that is where I do my best work I. I have found a lot of my guests through social media.
In 2023, the Royal College of Emergency Medicine and the UK Clinical Pharmacy Association recommended all EDs have a dedicated pharmacist and, as of 2024, approximately 77 of 170 UK EDs (45%) have a clinical pharmacy service. Pharm J; 26 March 2024. Accessed June 2024]. Greenwood D et al. Int J Clin Pharm 2019;41:434–44.
Pilot participants were provided a technical package containing all resources needed to accurately calculate the SP-TAT-PH measure. For example, one participant described how varying levels of “urgency” could be communicated to pharmacists, empowering them to prioritize prescriptions for expedited review. on October 8, at 4:30 p.m.
FDA is expected to provide initial feedback on the data submitted by July 2024, with further data to be collected and analysed over the next two years. How does the qualification package support more meaningful endpoints and rare disease research as a result?
The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. However, issues arose due to a lack of PAAP, insufficient communication between or within services and families, failure to recognise child deterioration, and treatment delays.
AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects. 2024 [cited 2025Feb]. 2024 [cited 2025Feb]. 2024 ;234:3418. Nature Communications. 17 AI also has useful applications in GMP manufacturing of drug substance and drug products. cited 2025Feb].
Sustainable practises in healthcare benefit everyone ePI represents a step towards reducing the environmental footprint of pharmaceutical supply chains by eliminating paper leaflets and reducing packaging size. Moreover, fostering a culture of transparency and open communication will help build trust and encourage widespread adoption.
In the UK, the Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024 1 have passed through the UK legislative procedure and will apply from 23 July 2025. In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content